TENOFOVIR VERSUS ENTECAVIR FOR HEPATOCELLULAR CARCINOMA PREVENTION IN AN INTERNATIONAL CONSORTIUM OF CHRONIC HEPATITIS B

被引：0

作者：

Hsu, Yao-Chun ^{[1
]}

Wong, Grace Lai-Hung ^{[2
,3
]}

Chen, Chien Hung ^{[4
]}

Peng, Cheng-Yuan ^{[5
]}

Yeh, Ming-Lun ^{[6
]}

Cheung, Ka-Shing ^{[7
]}

Toyoda, Hidenori ^{[8
]}

Huang, Chung-Feng ^{[9
]}

Trinh, Huy N. ^{[10
]}

Xie, Qing ^{[11
]}

Enomoto, Masaru ^{[12
]}

Liu, Li ^{[13
]}

Yasuda, Satoshi ^{[8
]}

Tanaka, Yasuhito ^{[14
,15
]}

Kozuka, Ritsuzo ^{[12
]}

Tsai, Pei-Chien ^{[6
]}

Huang, Yen-Tsung ^{[16
]}

Wong, Christopher ^{[17
]}

Huang, Rui ^{[18
]}

Jang, Tyng-Yuan ^{[19
]}

Hoang, Joseph ^{[20
]}

Yang, Hwai-I ^{[21
]}

Li, Jiayi ^{[22
]}

Lee, Dong Hyun ^{[23
]}

Takahashi, Hirokazu ^{[24
]}

Zhang, Jianqing ^{[25
]}

Ogawa, Eiichi ^{[26
]}

Zhao, Changqing ^{[27
]}

Liu, Chenghai ^{[28
]}

Furusyo, Norihiro ^{[26
]}

Eguchi, Yuichiro ^{[29
]}

Wong, Clifford ^{[17
]}

Wu, Chao ^{[18
]}

Kumada, Takashi ^{[30
]}

Yuen, Man-Fung ^{[31
]}

Yu, Ming-Lung ^{[6
]}

Nguyen, Mindie H. ^{[20
]}

机构：

[1] I Shou Univ, Kaohsiung, Taiwan

[2] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Peoples R China

[3] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China

[4] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan

[5] China Med Univ, Sch Med, Taichung, Taiwan

[6] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[7] Queen Mary Hosp, Med, Hong Kong, Peoples R China

[8] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu, Japan

[9] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[10] San Jose Gastroenterol, San Jose, CA USA

[11] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China

[12] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka, Japan

[13] Third Hosp Kumming City, Kunming, Yunnan, Peoples R China

[14] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan

[15] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan

[16] Acad Sinica, Taipei, Taiwan

[17] Wong Clin, Singapore, Singapore

[18] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Infect Dis,Affiliated Hosp, Nanjing, Jiangsu, Peoples R China

[19] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan

[20] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA

[21] Acad Sinica, Genom Res Ctr, Taipei, Taiwan

[22] Palo Alto Med Fdn, Mt View Div, Palo Alto, CA USA

[23] Good Gang An Hosp, Busan, South Korea

[24] Saga Univ, Fac Med, Div Endocrinol & Metab, Saga, Japan

[25] Chinese Hosp, Beijing, Peoples R China

[26] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka, Fukuoka, Japan

[27] Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China

[28] Shanghai Univ TCM, Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China

[29] Saga Med Sch, Fac Med, Dept Internal Med, Saga, Japan

[30] Ogaki Municipal Hosp, Ogaki, Gifu, Japan

[31] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

459

引用

页码：290A / 291A

页数：2

共 50 条

[1] Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
Hsu, Yao-Chun
Wong, Grace Lai-Hung
Chen, Chong
Peng, Cheng-Yuan
Yeh, Ming-Lun
Cheung, Ka-Shing
Toyoda, Hidenori
Huang, Chung-Feng
Huy Trinh
Xie, Qing
Enomoto, Masaru
Liu, Li
Yasuda, Satoshi
Tanaka, Yasuhito
Kozuka, Ritsuzo
Tsai, Pei-Chien
Huang, Yen-Tsung
Wong, Christopher
Huang, Rui
Jang, Tyng-Yuan
Hoang, Joseph
Yang, Hwai-, I
Li, Jiayi
Lee, Dong-Hyun
Takahashi, Hirokazu
Zhang, Jian Q.
Ogawa, Eiichi
Zhao, Changqing
Liu, Chenghai
Furusyo, Norihiro
Eguchi, Yuichiro
Wong, Clifford
Wu, Chao
Kumada, Takashi
Yuen, Man-Fung
Yu, Ming-Lung
Nguyen, Mindie H.
[J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (02): : 271 - 280
[2] Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B
Kamal, Faisal
Khan, Muhammad Ali
Ahmed, Aijaz
Nair, Satheesh
[J]. GUT, 2020, 69 (11) : 2054 - +
[3] Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B
Choi, Won-Mook
Choi, Jonggi
Wong, Grace Lai-Hung
Han, Seungbong
Lim, Young-Suk
[J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02): : 87 - 87
[4] Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma
Lee, Sung Won
Choi, Jonggi
Kim, Seung Up
Lim, Young-Suk
[J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (03) : 402 - 412
[5] Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B?
Yuan, Bao-Hong
Zhu, Yan-Kun
Li, Ru-Hong
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (02) : 314 - 315
[6] Comparison of Tenofovir and Entecavir in the Prevention of Hepatocellular Carcinoma Occurrence in Patients with Chronic Hepatitis B
Facciorusso, Antonio
Cincione, Ivan
Sacco, Rodolfo
[J]. LIVER CANCER, 2021, 10 (03) : 285 - 286
[7] Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis
Huang, Rui
Liu, Jiacheng
Wang, Jian
Wu, Chao
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 1040 - 1041
[8] Entecavir versus Tenofovir for the Prevention of Hepatocellular Carcinoma in Treatment-naive Chronic Hepatitis B Patients in Korea
Choi, HeeKyoung
Seo, Gi Hyeon
[J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (14) : 1 - 10
[9] Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors' reply
Yip, Terry C. -F.
Wong, Grace L. -H.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (02) : 315 - 316
[10] Is tenofovir disoproxil fumarate superior to entecavir for prevention of hepatocellular carcinoma in patients with chronic hepatitis B?
van Velsen, Lisa M.
Sonneveld, Milan J.
van Erpecum, Karel J.
[J]. HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (06) : 919 - 922

← 1 2 3 4 5 →